Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20101
20112
20163
20171
20201
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated5
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Spyre Therapeutics, Inc.2
Amgen1
Applied Molecular Transport1
Arena Pharmaceuticals1
AstraZeneca1
Facet Biotech1
Novartis Pharmaceuticals1
OSE Immunotherapeutics1
Protagonist Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases14
Colitis, Ulcerative8
Crohn Disease4
Colitis3
Gastrointestinal Diseases2
Colonic Diseases1
Digestive System Diseases1
Inflammation1
Intestinal Diseases1
Irritable Bowel Syndrome1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.